Join the club for FREE to access the whole archive and other member benefits.

Landmark moment in lymphoma CAR T cell treatment


Key points from article :

Four in 10 patients with aggressive lymphoma were cancer-free 15 months after treatment.

US clinical trial involved 108 patients with large B cell lymphoma.

CAR T cell therapy boosts the immune system’s ability to recognise and destroy cancer cells.

Studies are also underway in the UK to test the treatment.

CAR T was also shown to have long-term benefits with non Hodgkin lymphoma patients.

The study was published in the New England Journal of Medicine.

Mentioned in this article:

Tap on icon for description, click on resource name for more details.


Independent cancer charity focused on saving lives through research, influence and information


Assistant Professor at Moffitt Cancer Center, medical oncologist and translational researcher.


Scientific Journal devoted to medical research.